MUC-16 targeting program (iBio)

N/A

Report date: 2025/03/20 15:25:14

Base Information

Drug NameMUC-16 targeting program (iBio)
Drug Alias Nameanti MUC-16 mAb (iBio)
ClassificationBiologics
Mechanisms of ActionMucin-16 modulators
TargetsMucin-16
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesIbio Inc
China Registration ClassN/A

Develop Information

Active CompaniesIbio Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A